Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan

NEXT STORY
Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market
PREV STORY
Inventiva’s 2020 Full-Year Financial Results Presentation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Quipt Adds $13 Million in Annualized Revenue, $1.6 Million in Net Income, Anticipated $2.9 Million of Adjusted EBITDA Post Integration and 15,000 New Active Patients With Acquisition of Indiana Based Company

author_avatar
NASDAQ Market News

Insights on the Liquid Handling System Global Market to 2026 – Competitive Analysis and the Impact of COVID-19

author_avatar
NASDAQ Market News

CoLucid Pharmaceuticals Announces Initiation of Second Phase 3 Pivotal Trial of Lasmiditan in Migraine

First Patient Randomized in SPARTAN StudyTrial Being Conducted Under Special Protocol Assessment Agreement with ...

author_avatar
NASDAQ Market News